PortfoliosLab logoPortfoliosLab logo
AREC vs. APYX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

AREC vs. APYX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Resources Corporation (AREC) and Apyx Medical Corporation (APYX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AREC vs. APYX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
AREC
American Resources Corporation
-2.42%145.54%-32.21%12.88%-26.67%-7.69%209.52%-93.37%
APYX
Apyx Medical Corporation
5.43%121.52%-39.69%11.97%-81.75%78.06%-14.89%26.46%

Fundamentals

Market Cap

AREC:

$204.02M

APYX:

$155.58M

EPS

AREC:

-$0.48

APYX:

-$0.27

PS Ratio

AREC:

1.39K

APYX:

2.92

Total Revenue (TTM)

AREC:

$145.03K

APYX:

$52.10M

Gross Profit (TTM)

AREC:

$140.16K

APYX:

$33.04M

EBITDA (TTM)

AREC:

-$22.47M

APYX:

-$5.09M

Returns By Period

In the year-to-date period, AREC achieves a -2.42% return, which is significantly lower than APYX's 5.43% return.


AREC

1D
8.04%
1M
-19.33%
YTD
-2.42%
6M
-10.37%
1Y
417.98%
3Y*
17.28%
5Y*
-8.61%
10Y*

APYX

1D
3.07%
1M
12.84%
YTD
5.43%
6M
72.43%
1Y
169.34%
3Y*
8.61%
5Y*
-17.68%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AREC vs. APYX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AREC
AREC Risk / Return Rank: 9393
Overall Rank
AREC Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
AREC Sortino Ratio Rank: 9595
Sortino Ratio Rank
AREC Omega Ratio Rank: 9090
Omega Ratio Rank
AREC Calmar Ratio Rank: 9595
Calmar Ratio Rank
AREC Martin Ratio Rank: 8989
Martin Ratio Rank

APYX
APYX Risk / Return Rank: 8888
Overall Rank
APYX Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
APYX Sortino Ratio Rank: 8888
Sortino Ratio Rank
APYX Omega Ratio Rank: 8383
Omega Ratio Rank
APYX Calmar Ratio Rank: 9494
Calmar Ratio Rank
APYX Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AREC vs. APYX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for American Resources Corporation (AREC) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARECAPYXDifference

Sharpe ratio

Return per unit of total volatility

2.55

1.65

+0.90

Sortino ratio

Return per unit of downside risk

3.52

2.64

+0.87

Omega ratio

Gain probability vs. loss probability

1.39

1.31

+0.07

Calmar ratio

Return relative to maximum drawdown

5.73

5.05

+0.68

Martin ratio

Return relative to average drawdown

9.74

11.31

-1.58

AREC vs. APYX - Sharpe Ratio Comparison

The current AREC Sharpe Ratio is 2.55, which is higher than the APYX Sharpe Ratio of 1.65. The chart below compares the historical Sharpe Ratios of AREC and APYX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ARECAPYXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.55

1.65

+0.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.08

-0.18

+0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

-0.09

+0.17

Correlation

The correlation between AREC and APYX is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AREC vs. APYX - Dividend Comparison

Neither AREC nor APYX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AREC vs. APYX - Drawdown Comparison

The maximum AREC drawdown since its inception was -97.12%, roughly equal to the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for AREC and APYX.


Loading graphics...

Drawdown Indicators


ARECAPYXDifference

Max Drawdown

Largest peak-to-trough decline

-97.12%

-94.99%

-2.13%

Max Drawdown (1Y)

Largest decline over 1 year

-68.72%

-32.17%

-36.55%

Max Drawdown (5Y)

Largest decline over 5 years

-89.94%

-94.99%

+5.05%

Current Drawdown

Current decline from peak

-82.71%

-78.79%

-3.92%

Average Drawdown

Average peak-to-trough decline

-79.64%

-56.43%

-23.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

40.45%

16.25%

+24.20%

Volatility

AREC vs. APYX - Volatility Comparison

The current volatility for American Resources Corporation (AREC) is 21.41%, while Apyx Medical Corporation (APYX) has a volatility of 25.51%. This indicates that AREC experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ARECAPYXDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.41%

25.51%

-4.10%

Volatility (6M)

Calculated over the trailing 6-month period

97.71%

55.45%

+42.26%

Volatility (1Y)

Calculated over the trailing 1-year period

165.48%

103.25%

+62.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.24%

98.94%

+8.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

746.33%

93.04%

+653.29%

Financials

AREC vs. APYX - Financials Comparison

This section allows you to compare key financial metrics between American Resources Corporation and Apyx Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
50.17K
18.42M
(AREC) Total Revenue
(APYX) Total Revenue
Values in USD except per share items